Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Colorado State University
Karyopharm Therapeutics Inc
Cancer Research UK
Carevive Systems, Inc.
Essen Biotech
Azienda Ospedaliero-Universitaria di Parma
Royal Marsden NHS Foundation Trust
University of Nebraska
Adela, Inc
Mayo Clinic
Cancer Research UK
Incyte Corporation
Arcus Biosciences, Inc.
University of Alabama at Birmingham
Baxter Healthcare Corporation
Compugen Ltd
University of Alberta
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Taproot Health
Cedars-Sinai Medical Center
Sanguine Biosciences
Cancer Support Community, Research and Training Institute, Philadelphia
Gilead Sciences
Incyte Corporation
Scripps Health
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Celgene
Shenzhen BinDeBio Ltd.
Vanderbilt-Ingram Cancer Center
City of Hope Medical Center
CureOne
Vanderbilt-Ingram Cancer Center
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Amgen
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
OHSU Knight Cancer Institute
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Rutgers, The State University of New Jersey